Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipid bilayer phospholipids form the essential structural framework of cellular and organelle membranes, maintaining cellular compartmentalization and fluidity (Ayala et al., 2014, PMID: 24926803). Membrane-associated free radicals, including reactive oxygen species (ROS) and lipid peroxyl radicals, are highly reactive intermediates that can trigger lipid peroxidation, a process that degrades these phospholipids and compromises membrane integrity (Gaschler & Stockwell, 2017, PMID: 28213273). This oxidative damage is a hallmark of various pathological states, particularly neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and ischemia-reperfusion injury in stroke (Watanabe et al., 1994, PMID: 8034141). Therapeutic strategies targeting this system involve lipophilic antioxidants and radical scavengers, such as Edaravone and Vitamin E, which localize within the membrane to neutralize radicals and terminate the peroxidation chain reaction (NIH, 2023). By protecting the lipid environment, these interventions aim to preserve the function of membrane-bound proteins and prevent oxidative-stress-induced cell death (Repetto et al., 2012, PMID: 23110314).
Drugs targeting this complex act primarily as chain-breaking antioxidants or free radical scavengers. They partition into the hydrophobic core of the lipid bilayer where they donate hydrogen atoms to lipid peroxyl radicals, thereby neutralizing them and preventing the propagation of lipid peroxidation (Ayala et al., 2014, PMID: 24926803).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid bilayer phospholipids and membrane-associated free radicals.